Schizophrenia Clinical Trials

83 studies are recruiting for schizophrenia in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Atlanta, Georgia 21 Chicago, Illinois 20 Little Rock, Arkansas 16 Hollywood, Florida 14 Austin, Texas 13 Boston, Massachusetts 13 Garden Grove, California 13 New York, New York 13 Houston, Texas 12 Miami, Florida 12 Miami Lakes, Florida 12 Decatur, Georgia 11 Gaithersburg, Maryland 11 San Diego, California 11 Culver City, California 10 Richardson, Texas 10 DeSoto, Texas 9 Marlton, New Jersey 9 Anaheim, California 8 Lemon Grove, California 8 Philadelphia, Pennsylvania 8 West Palm Beach, Florida 8 Belmont, Massachusetts 7 Cincinnati, Ohio 7 Las Vegas, Nevada 7 Los Angeles, California 7 Pittsburgh, Pennsylvania 7 Riverside, California 7 Staten Island, New York 7 Torrance, California 7 Bentonville, Arkansas 6 Chino, California 6 Dallas, Texas 6 Oceanside, California 6 Orange, California 6 Pico Rivera, California 6 St Louis, Missouri 6 Bellevue, Washington 5 Bellflower, California 5 Hialeah, Florida 5 North Canton, Ohio 5 Orlando, Florida 5 Richmond, Virginia 5 Rogers, Arkansas 5 The Bronx, New York 5 Worcester, Massachusetts 5 Bryant, Arkansas 4 Everett, Washington 4 Flowood, Mississippi 4 Fort Worth, Texas 4 Hartford, Connecticut 4 Lincoln, Nebraska 4 Montclair, California 4 Nashville, Tennessee 4 Oklahoma City, Oklahoma 4 Snellville, Georgia 4 Stanford, California 4 Tampa, Florida 4 Watertown, Massachusetts 4 Athens, Georgia 3

Studies, page 4

  1. The Effects of Auditory Stimulation During Sleep on Brain Networks in Schizophrenia

    In this research study the investigators will use sleep headbands to measure brain rhythms and to improve their coordination across brain regions. The headbands will be worn at home for multiple nights. On some nights the headbands will play soft sounds at specific times during sleep. The investiga…

    Stage
    Not phased
    Ages
    18 to 45
    Site
    Massachusetts General Hospital, Charlestown, Massachusetts
    Run by
    Massachusetts General Hospital

    See if you can join NCT06386588 on ClinicalTrials.gov

  2. Neuronal Effects of Exercise in Schizophrenia

    This study plans to learn more about how common drugs prescribed to individuals with schizophrenia contribute to weight gain, as well as how exercise and diet impact appetite and the brain's response to food. In this study, the investigators will be evaluating how participants' brains respond to fo…

    Stage
    Not phased
    Ages
    21 to 70
    Site
    University of Colorado Anschutz Medical Campus, Aurora, Colorado
    Run by
    University of Colorado, Denver

    See if you can join NCT02455193 on ClinicalTrials.gov

  3. Safety and Tolerability of Open-Labeled Iloperidone in Adolescents

    To evaluate the safety and tolerability of iloperidone in adolescent patients with schizophrenia or bipolar I disorder for up to 52 weeks of treatment.

    Stage
    Phase 4
    Ages
    12 to 17
    Site
    Vanda Investigational Site, Little Rock, Arkansas
    Locations
    9 in total
    Run by
    Vanda Pharmaceuticals

    See if you can join NCT05648591 on ClinicalTrials.gov

  4. Cognitive Training for Emotion Regulation in Psychotic Disorders

    The current study examines the efficacy of a cognitive training intervention for improving emotion regulation in psychotic disorders. it is hypothesized that the cognitive training program will enhance prefrontal activation, leading to enhanced emotion regulation.

    Stage
    Not phased
    Ages
    18 to 60
    Site
    University of Georgia, Athens, Georgia
    Run by
    University of Georgia

    See if you can join NCT04414215 on ClinicalTrials.gov

  5. Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia

    This study is to evaluate the effect and safety of Brilaroxazine in patients with acute schizophrenia compared to the placebo short and long-term. Brilaroxazine will be given at fixed doses of 15 mg or 50 mg once daily over 4 weeks, then in the long-term flexible doses 15-50mg daily over a period o…

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    Reviva site, Phoenix, Arizona
    Locations
    18 in total
    Run by
    Reviva Pharmaceuticals

    See if you can join NCT05184335 on ClinicalTrials.gov

  6. Imaging Synapses With [11C] UCB-J in the Human Brain

    The purpose of this study is to utilize the radioactive positron emission tomography (PET) tracer [11C]UCB-J to test the neural synaptic pruning hypothesis of schizophrenia. This imaging method allows for the quantification of synaptic density in the living human brain and has the unprecedented abi…

    Stage
    Phase 1
    Ages
    18 to 65
    Site
    VA Palo Alto Health Care System, Palo Alto, California
    Locations
    2 in total
    Run by
    Davidzon, Guido, M.D.

    See if you can join NCT04038840 on ClinicalTrials.gov

  7. Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.

    This study is looking to determine if Lumateperone improves motivation in patients with schizophrenia or schizoaffective disorders who show high levels of apathy as judged by AES-C-Apathy (Apathy Evaluation Scale - Clinician - Apathy) assessment and to examine a possible correlation between improve…

    Stage
    Phase 3
    Ages
    18 to 65
    Site
    LSU Health Shreveport, Shreveport, Louisiana
    Run by
    Louisiana State University Health Sciences Center Shreveport

    See if you can join NCT06482554 on ClinicalTrials.gov

  8. Smoking Cessation With Varenicline in Schizophrenia: Antipsychotic-Induced Neurological Symptoms as Correlates

    To test the feasibility of studying effects of smoking cessation with varenicline on antipsychotic drug-induced neurological side effects, we propose a 12 week pilot study of smoking cessation treatment with varenicline in 10 schizophrenia or schizoaffective disorder patients who are actively smoki…

    Stage
    Phase 4
    Ages
    18 to 75
    Site
    Corporal Michael J Crescenz VA Medical Center, Philadelphia, Pennsylvania
    Run by
    Corporal Michael J. Crescenz VA Medical Center

    See if you can join NCT03495024 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.